drugset / Trial / NCT00198276

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

NCT00198276

Phase 4 Completed 88 enrolled Inovio Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to study the safety and efficacy of MedPulser Electroporation with bleomycin treatment of cutaneous and subcutaneous foci of cancer.

Timeline

Start
2004-02
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown 1 unknown Other

Indications